Search - tctmd.com

Displaying 321 - 340 of 576

Sort: Relevancy | Date

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Daily News

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Michael O'Riordan

June 22, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

COVID-19 Upset: Researchers Retract Lancet, NEJM Papers on Hydroxychloroquine, ACEi/ARBs

Michael O'Riordan

June 04, 2020

News Daily News

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

Michael O'Riordan

May 29, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

Advertisement

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Thrombus Burden Greater in STEMI Patients With COVID-19

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

COVID-19 Upset: Researchers Retract Lancet, NEJM Papers on Hydroxychloroquine, ACEi/ARBs

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content